Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled Corticosteroids (MILLY)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00930163
Recruitment Status : Completed
First Posted : June 30, 2009
Last Update Posted : November 29, 2016
Sponsor:
Information provided by (Responsible Party):
Genentech, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2010
Actual Study Completion Date : September 2010
Certification/Extension First Submitted : June 30, 2011